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Radioactive 2-hydroxystearic and cerebronic acids were converted to the coensyme 
A thio esters, then tested for reactivity with n-sphingosine. Microsomes from mouse 
brain were found to catalyze the formation of ceramides containing both hydroxy 
acids. Both the D- and L-forms of the hydroxy acids reacted. Comparisons of reac- 
tivity were made with stearoyl and lignoceroyl CoA, the analogous nonhydroxy 
acids, which also form ceramides. The ratios of activities of the substrates were 
found to vary with animal age, with various subcellular fractions, with different rat 
brain cell preparations, and with different mouse organs. Competition experiments 
with mixtures of thio ester substrates showed that stearate and lignocerate did not 
interfere with each other in the formation of ceramide, but hydroxystearoyl CoA 
inhibited the utilization of the two nonhydroxy substrates and cerebronoyl CoA 
inhibited the utilization of lignoceroyl CoA. The kinetics of the inhibitions indicated 
that the effects were noncompetitive. A similar type of inhibition was seen with 
stearoyl CoA against hydroxystearate incorporation, On the basis of these findings, 
we suggest that four different enzymes are involved in the acyl transfer reaction: for 
stearate, hydroxystearate, lignocerate, and cerebronate. Neuronal cell preparations 
were found to be relatively rich in stearate transferase, while glial cells were rela- 
tively rich in hydroxystearate and lignocerate transferases. 
Ceramides (the fatty acyl amides of 
sphingosine and related long chain bases) 
are the precursors of the sphingoglycolipids 
and, perhaps, of sphingomyelin (l-6). The 
NFA3 ceramides are converted to galacto- 
cerebroside (2) and glucocerebroside (2, 3) 
while the HFA ceramides are converted to 
galactocerebroside (1, 4). A curious feature 
becomes evident when the chain lengths of 
the fatty acids are examined: two clusters 
are seen, centering around the Cl8 acids and 
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around the G4 acids (7). Very little C& , CzO ’ 
or Czl is seen. The distribution within brain 
or other organs varies considerably with re- 
spect to the two clusters and the ratio of 
NFA and HFA. It is thus plausible to con- 
sider that several ceramide-forming enzymes 
exist, with differing specificities with respect 
to chain length and the hydroxyl group. This 
study presents a test of this hypothesis as 
well as some characterization of the enzymes. 
Formation of 16:0 ceramide (palmitoyl 
amides) by rat brain and chicken liver micro- 
somes has been demonstrated by Sribney, 
using palmitoyl CoA and a mixture of long 
chain bases (8). A study in mouse brain con- 
firmed the nature of the reaction and noted a 
wide difference in reaction rates with 16:0, 
18:0, 18:1, and 24:0, from which it was 
concluded that the ceramide-forming system 
may control the chain length distribution in 
sphingolipids (9). 
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The possibility had to be considered that 
HFA ceramides arise, not by acylation of 
long chain bases with HFA CoA, but by hy- 
droxylation of NFA ceramides. As a test of 
this possibility we prepared labeled HFA 
CoA synthetically and looked for the en- 
zymatic reaction with sphingosine. 
MATERIALS AND METHODS 
Materials. Nonradioactive NFA were purchased 
from The Hormel Institute and converted to 
HFA.4 The free acid form of CoA (Calbiochem was 
used for the synthesis of acyl CoA’s. The prepara- 
tion of D-erythro-sphingosine, synthetic ceramide 
standards, and carboxyl-labeled lignoceric acid 
was described previously (2). Carboxyl-labeled 
stearic acid (New England Nuclear Corp.) and 
lignoceric acid were converted to the nL-2-hydroxy 
acids.” Subcellular preparations were made from 
Swiss-Webster CF-1 mice (Carworth Farms). Male 
mice were used except for l-day-old mice, when a 
random mixture of sexes was used. 
Neuronal and glial cell preparations were made 
as described before (lo), starting with the cerebral 
cortex of 16-day-old Sprague-Dawley rats. The 
neuronal perikarya were homogenized in 0.25 M 
sucrose and centrifuged 40 min at 100,OOOg. The 
glial preparations, which were obtained in low 
yield, were used without the disruption step. Ad- 
ditional glial cell-enriched fractions were pre- 
pared in Tris-salts buffer as described before (11) 
and shipped frozen. After thawing, the superna- 
tant fluid was decanted, the sediment surface was 
washed with water, the sediment was suspended 
in 0.25 11~ sucrose, and the suspension was centri- 
fuged as before. 
Subcellular fractions of brain were prepared 
according to De Robertis et al. (12). Fractions 
isolated from the gradient were diluted with 0.25 M 
sucrose and sedimented as before. Microsomes 
were prepared according to Morel1 and Radin 
(1) ; these were used for most experiments. 
In all cases, the pellets were suspended in 0.25 M 
sucrose, generally at a concentration of 20 mg 
protein/ml. The protein concentration was deter- 
mined with the biuret method (13), except in the 
case of the Sellinger glia, where the Lowry method 
(14) was used. Corrections for sucrose content 
were made. 
Analytical methods. Thin-layer chromatog- 
raphy, with 0.5-mm layers of Silica Gel PF-254 
(Brinkmann-Merck), was used to characterize all 
compounds and isolate enzyme products (9, 15). 
Labeled NFA ceramide was separated with C-M- 
4 R. C. Arora and N. S. Radin, method to be 
described. 
acetic acid 90:2:8 and HFA ceramide was sepa- 
rated on borate-containing plates (9) with C-M 
9O:lO. To determine the 14C in the free HFA and 
polar lipids formed in incubation with HFA-CoA, 
we recovered the lipids (in 98% yield) in the 
sample origin spot as described before (9) and 
separated them on oxaiate-impregnated TLC 
plates with C-M-water 3:3:1 (16). This system is 
particularly good for free HFA. 
Assay for cerawkde biosynthesis. A solution of 
n-sphingosine (0.2 mg in benzene) was evaporated 
in a 13 X 100 mm screw cap test tube, and a sus- 
pension of microsomes (or other particles) con- 
taining 2 mg protein was added. To this were 
added 12.5 rmoles KP04 (pH 7.4), then 80 nmoles 
%-fatty acyl CoA. The mixture was diluted with 
0.25 M sucrose to a final volume of 0.25 ml (final 
sucrose concentration was about 0.20 M). The tube 
was capped, sonicated at 0°C in a cleaning bath to 
disperse the sphingosine, and then shaken at 
37°C for 15 min. 
To recover the reaction products we added 4 ml 
of C-M2: 1, filtered the mixture through analytical 
reagent Celite (Johns-Manville) to remove pro- 
tein, washed the incubation tube and funnel with 
1 ml more of C-M, then washed the filtrate with 1 
ml of 0.2 M KCl. The lower layer, after centrifuga- 
tion, was washed with 2.5 ml of M-water 1:l and 
applied to a TLC plate together with 0.1 mg of 
mixed (NFA and HFA) ceramides as carrier. The 
spots obtained after solvent development were 
located by iodine vapor and radioautography, 
then scraped off and counted by liquid scintillation 
(15). At least 90% of the 14C in the incubation tube 
was accounted for by the various TLC spots and 
upper layer washes. The remaining activity was 
found in the Celite-protein filter cake. 
Enzyme activities are expressed as nanomoles 
ceramide produced in 15 min by 2 mg of protein. 
Synthesis of HFA and NFA CoA derivatives. 
The fatty acyl CoA’s were prepared by the meth- 
ods of Al-Arif and Blecher (17) and Kawanami 
(18), with modifications made to compensate for 
the fact that labeled fatty acids were involved 
and for the special needs of the less soluble, less 
reactive longer chain acids. 
The first step is the formation of acyl esters of 
N-hydroxysuccinimide. Thirty micromoles each 
of fatty acid, hydroxysuccinimide, and N,N’- 
dicyclohexylcarbodiimide are dissolved in 4-5 ml 
of dioxane-ethyl acetate 7:3. Both solvents are 
dried over molecular sieve. The container is 
capped and heated at 60°C overnight, then cooled 
in ice to complete the precipitation of dicyclohexyl 
urea. Brief centrifugation is used to remove the 
soluble portion and to wash the precipitate with 
3 X 2 ml of the same solvent mixture. The com- 
bined supernatants are dried with a stream of 
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nitrogen in a 50’C-water bath, after examination 
of a portion by TLC. Using silica gel plates and 
hexane-ether-acetic acid 50:50:7, one finds the 
fatty acid eater at about R, 0.5. The urea deriva- 
tive does not migrate, while free HFA and dicyclo- 
hexylcarbodiimide migrate to 0.8. Radioautog- 
raphy with these plates shows three faint 
radioactive products, besides the major ester 
spot; one is free fatty acid and the other two 
have higher Rf values. 
It may be necessary to distill the dicyclohexyl- 
carbodiimide (under vacuum) to purify it. The 
dioxane and tetrahydrofuran (see later) are dis- 
tilled from KOH pel1et.s before drying. 
To the dry ester are added 33 pmoles of CoA 
(calculated from the purity data on the bottle) in 
1.5 ml water, then 42 mg sodium bicarbonate and 
enough tetrahydrofuran (about 4 ml) to clarify 
the mixture. The mixture is stirred with bubbling 
nitrogen to speed the dissolving, then capped and 
left for 4 hr. The acyl CoA is precipitated with 7 
ml of 4% perchloric acid (w/w) and the mixture is 
concentrated slightly with a stream of nitrogen, 
the tube being suspended in air rather than a 
water bath. On centrifugation of the mixture, one 
sees a small amount of floating material (free fatty 
acid) which can be drawn off with a pipet and re- 
covered for reuse. The precipitated acyl CoA is 
washed with 3 ml of 0.8% perchloric acid by 
centrifugation. Additional washing is carried out 
similarly with 3 X 3 ml acetone, with the aid of an 
ultrasonic cleaning bath. In the case of the very 
long chain acids or the HFA, two additional wash- 
ings with warm (50°C) ethyl acetate are carried 
out. Two more washings with ether are followed 
by brief drying under a nitrogen stream and final 
drying in a vacuum desiccator. The tube is capped 
loosely before evacuating; otherwise the powder 
may fluff out. (Attempts to dry the product com- 
pletely with a nitrogen stream alone tend to yield 
losses due to fluffing.) 
Occasional runs, for indeterminate reasons, give 
CoA esters that are somewhat contaminated with 
free fatty acid, as evidenced by turbidity in aque- 
ous solutions. In such an event, add C-M to form 
a “Folch partition, ” in which the acyl CoA goes 
int,o the upper phase and the fatty acid goes into 
the lower phase. Wash the lower phase with 
M-water l:l, pool the upper phases, and precipi- 
tate the ester with perchloric acid as before. 
Nitrogen must be bubbled briefly through the 
upper layer to remove chloroform and precipitate 
t)he ester. 
Yields are roughly 70’% and radiopurity, tested 
by radioautography on oxalate TLC plates, is at 
least 95%. The ratio of absorbances at 232 and 
260 nm is 0.561 for hlS:O-Cob, which is the ex- 
pected value. 
RESULTS 
Demonstration of the formation of HFA 
cerumde. Enzymatic formation of HFA 
ceramide from the CoA thio ester and D- 
sphingosine could readily be observed. How- 
ever, some experimentation was needed to 
refine the TLC separation system, partially 
because of the complication introduced by 
the use of m-labeled acids. In applying the 
previously used method for determining 
ceramide formation (9), we found in the 
case of HFA that the free acid TLC spot 
trailed into the HFA ceramide spot. The 
trailing phenomenon with TLC of HFA was 
not so noticeable with small, nonradioactive 
spots but it was quite evident on radioauto- 
graphs. Another problem arose from the for- 
mation of L-HFA ceramide, due to nonspe- 
cific utilization by the enzyme of both forms 
of the DL-HFA CoA; this spot moved ahead 
of the natural HFA ceramide and coincided 
with the free HFA. The problems were 
solved by the use of borate plates, on which 
the free acids did not migrate. The RI values 
for the different ceramides were: L-h18:O 
0.29; D-h18:O 0.21; L-h24:O 0.33; n-h24:O 
0.25. 
When separation of the enzymatic 
products from NFA incubations was at- 
tempted with borate plates, it was found that 
the free NFA migrated with the NFA cera- 
mide. Evidently the failure of free HFA to 
migrate on such plates is due to formation of 
a cyclic borate ester salt, or to the increased 
ionization characteristic of 2-hydroxy acids. 
The biosynthesized HFA ceramides were 
characterized further by recovery from the 
borate plate, mild alkaline methanolysis, 
and rechromatography on silica gel with 
C-M-acetic acid. Again the ceramides mi- 
grated with the standards, being separated 
according to chain length and optical ac- 
tivity. The negligible loss of activity during 
this process confirmed the purity of the spots 
on the borate plates. 
The faster migration of I,-HFA sphingo- 
lipids on TLC plates had been noted earlier 
in the case of cerebrosides (19) and cera- 
mides (20). In the case of mouse brain micro- 
somal incubations, the biosynthesized D- 
h18:O ceramide comprised 60% of the total 
ceramide formed; the n-h24:O ceramide ac- 
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ENZYMATIC AND NONENZYMATIC FORMATION OF 
HYDROXY CERAMIDE~ 
TABLE I TABLE II 
THF: EFFECT OF MODIFYING THI,: STANDARD BSSAY 
SYSTEM FOR HYDROXY CERAMIDE BIOSYNTHESIS 
BY MOUSE BRAIN MICROSOMES 
Protein Ceramide formed (nmoles) 
(w9 
h18:O hZ4:O 
<unheated) (heated) (unheated) (heated) 
- 
Additions to the system Ceramide formed 
h18:O h24:O 
0.00 1.21 1.27 
0.10 0.87 0.83 1.02 0.98 
0.25 0.64 0.53 0.64 0.56 
0.50 0.95 0.48 0.54 0.39 
1.00 1.18 0.22 0.60 0.23 
2.06 1.99 0.10 0.76 0.12 
3.00 2.93 0.08 0.88 0.10 
4.00 3.50 0.07 0.91 0.08 
a Mouse brain microsomes were incubated with 
0.2 mg of sphingosine and 80 nmoles of W-HFA 
coenzyme A for 15 min at 37°C. Control micro- 
somes were heated in boiling water for 10 min. 
(nmoles) 
None 
50 mM Tris pH 7.4-phosphate 
50 mM imidazole pH 7.&phos- 
phate 
4 nm MgC12 
4 mM MnC12 
4 mM CaC12 
4 mM EDTA 
4 mu ATP 
1 mM DTT 
4 mM MgClz + 4 mu EDTA 






counted for 40 %. Both isomers were counted 










In the absence of enzyme, a large amount of 
HFA ceramide was formed (Table I). In the 
presence of boiled enzyme, the amount of 
conversion was greatly reduced; this blank 
value was subtracted from each incubation 
value. Evidently the nonenzymatic reaction 
occurs when acyl CoA and sphingosine are 
in the free state, and this is reduced by bind- 
ing between some microsomal component 
(protein?) and one or both of the substrates. 
The data in Table I obtained with unheated 
microsomes show that this binding phenome- 
non took place with undenatured protein, 
as well as with heat-denatured protein. A 
distinct amount of binding occurred even at 
the low level of 0.1 mg protein and the extent 
of binding increased as a continuous function 
of the protein concentration (see “heated” 
columns). 
the sphingosine, yielded lower activities with 
HFA CoA. Maximal rates of synthesis were 
obtained with about 80-100 nmoles h18:O 
and about 140 nmoles h24:O (Fig. 1). For 
reasons of economy a value of 80 nmoles was 
used in the standard assay system for both 
CoA compounds. The rate of reaction was 
relatively independent of sphingosine con- 
centration between 0.2 and 0.6 mg per tube 
(Fig. 2). Under the conditions described for 
the assay system, the rates of synthesis of 
HFA ceramide were linear with time for 20 
min and proportional to protein concentra- 
tion up to nearly 3 mg (Table I). 
Incubation conditions. Tris and imidazole 
buffers were less effective than phosphate in 
the synthesis of HFA ceramides (Table II). 
Cations, EDTA, ATP, dithiothreitol, and 
several combinations of these did not stimu- 
late the reaction. Some inhibition was pro- 
duced by Mn2+ and dithiothreitol. Similar 
lack of stimulation had been not,ed in the 
similar system incubated with stearoyl 
CoA (9). 
Changes in ceramide synthesis with age. 
The ability of mouse brain microsomes to 
synthesize NFA and HFA ceramides was 
measured as a function of mouse age (Fig. 
3). The reaction with stearate was most 
rapid at all ages examined, while h24:O was 
least effective. A distinct difference was seen 
in the period 1-8 days, when the long chain 
acids (18:0 and h18:O) showed considerable 
rise in reaction rates while the very long 
chain acids (24:0 and h24:O) remained es- 
sentially constant in activity. All the acids 
declined in reactivity after 64 days. 
Tween 20 and Celite, coevaporated with 
The differences in reactivity of the four 
acyl GA’s are seen more clearly in Table 
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20 60 100 140 180 
ACYL-CoA (nmoler) 
FIG. 1. Rate of formation of HFA ceramides 
az a function of acyl CoA concentration (nmoles in 
0.25 ml). The standard assay system was used with 
brain microsomes from 16-day-old mice. A sepa- 
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Jo’ , I I I I I 
0.2 0.4 0.6 
SPHINGOSINE(ma) 
FIG. 2. Rate of formation of HFA ceramides as 
a function of sphingosine concentration (mg in 
0.25 ml). Assay conditions ss described in Methods 
section. 
III, which gives the ratio of activities of each 
acyl CoA with respect to stearate at each 
age point. Appreciable changes are seen with 
lignocerate and cerebronate, indicating that 
the stearate transferase is distinctly different 
from the transferase(s) for the very long 
1 4 8 16 32 64 128 
AGE(dovr) 
FIQ. 3. Ceramide-forming activity in mouse 
brain microsomes as a function of mouse age. Note 
the logarithmic age scale. 
TABLE III 
CERAMIDE FORMATION BY MOUSE BRAIN 
MICROSOMES AS A FUNCTION OF AGP 
Fatty acid Mouse age (days) 
activity 






0 Values shown are the ratios of the activities 
observed with each acyl CoA assayed. 
acids. Hydroxystearate, however, follows the 
stearate changes fairly closely and the same 
transferase could be acting on both acids. 
The bottom line in Table III gives the ratios 
for 24:0/h24:0 activities. The variations in 
these ratios (ranging from 1.25 to 1.83) sug- 
gest to us that two different transferases are 
involved in formation of the two very long 
chain ceramides. 
Subcellular distribution of the acyltrans- 
ferases. Ceramide synthesis was observed in 
all fractions for the three acids tested (Table 
IV). Microsomes possessed the highest spe- 
cific activity for all three activities. The 
second highest specific activity was found in 
the mitochondrial fraction in the case of 18:0 
transferase, in the nerve ending fraction in 
772 ULLMAN AND RADIN 
TABLE IV 
CERAMIDE FORMATION BY VARIOUS Mouse 
BRAIN SUBCELLULAR FRACTIONS’ 
Fraction 




Nerve ending fragments 
and debris 
Light nerve endings 
Heavy nerve endings 
Mitochondria 
Ceramide formed 
18:O 24:0 h18:O 
(nmoles) 
0.63 0.37 0.25 
1.72 0.54 0.86 
0.44 - 0.23 
0.33 0.11 0.23 
0.81 0.33 0.50 
0.58 0.18 0.27 
0.42 0.15 0.15 
1.29 0.28 0.16 
a The values shown were obtained with 2 mg of 
protein. A separate blank determination was made 
with each cell fraction, using boiled enzyme. Spe- 
cific activities of substrat,es (cpm/nmole) : 18:@- 
2OOO;h18:0-4700;24:0-3600. 
the case of h18.0 activity, and in the nuclear 
debris in the case of 24:O activity. The low 
activity toward h18:O in the mitochondrial 
fraction indicates to us that two distinct 
transferases are required for 18:0 and h18:O. 
Comparisrms of cell types. Activity toward 
three of the radioactive substrates was ob- 
served in both neuronal and glial cell prepa- 
rations furnished by Dr. Sellinger (Table V). 
Examination of the ratios of the activities 
(lower part of Table V) shows that glia are 
enriched in the enzymes which form h18:O 
and 24:0 ceramides, while neurons are en- 
riched in the stearate transferase. 
A similar comparison of Dr. Flangas’s glial 
cell types and total homogenate (Table 
VI) shows that all glial fractions are en- 
riched with respect to the h18:O and 24:0 
transferases. The degree of enrichment varies 
with cell type; for example, microglia show 
high enrichment for 24:0 transfer and only 
slight enrichment for hl8 : 0 transfer. 
Because the incubation conditions were 
not evaluated with each cell type and sub- 
cellular fraction the specific activities must 
be considered only approximate. 
Tests with mixtures of acyl coenzyme A thio 
esters. A simple test to determine whether 
two substrates are acted upon by a single en- 
zyme is the use of both substrates simul- 
TABLE V 
CERAMIDE SYNTHESIS BY RAT CORTEX 
CELL PREPARATIONS” 
Acyl CoA tested Ceramide formed -~.__~.__I_ 
Neurons Expressate Glia 
(nmoles) 
18:0 2.93 1.48 0.11 
24:0 1.20 0.48 0.40 
h18:O 1.54 1.08 0.24 
(ratio of activities) 
24:0/18:0 0.41 0.32 3.64 
h18:0/18:0 0.53 0.73 2.19 
n The expressate is that portion of the cortex 
which was expressed through a coarse sieve (the 
first step in isolating the cell types). Each incuba- 
tion tube contained 2 mg of protein except for the 
glia, which amounted to 0.4 mg protein (so the 
observed activities were multiplied by 5 for this 
table). Specific activities of acyl CoA’s (cpm/ 
nmole): 18:s21,000; h18:Q16,400; 24:0-15,000. 
TABLE VI 
CERAMIDE FORMED BY VARIOUS GLIAL CELL 




Microglia Oligoden- Astroglia Ex- 
droglia pressate 
(nmoles) 
18:O 0.24 0.32 0.20 0.92 
24:0 0.61 0.55 0.68 0.68 
h18:O 0.14 0.20 0.24 0.45 
(ratio of activities) 
24:0/18:0 2.54 1.72 3.40 0.74 
h18:0/18:0 0.58 0.63 1.20 0.49 
taneously at concentrations which yield 
maximal activity separately. Using our 
standard assay system with mouse brain 
microsomes, we incubated labeled ligno- 
ceroyl CoA with 0, 0.08,0.16,0.24, and 0.32 
mM unlabeled stearoyl CoA. No effect on the 
formation of lignoceroyl sphingosine was ob- 
served. A similar test with labeled 18:0 CoA 
showed only a slight inhibitory effect with 
24:0 CoA (9.5% at 0.24 mM>. This effect 
seems much too small to interpret as a com- 
petition for the active site and we therefore 
conclude that the long chain and very long 
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chain NFA acyltransferases are two distinct 
enzymes. 
The effect of h18:O CoA on the above two 
transferases was unexpected: both reactions 
were inhibited but the inhibition was of the 
noncompetitive type (Figs. 4A and 4B). The 
KI for stearate transferase, determined from 
the Dixon plot (35), was found to be 1.2 X 
1O-4 M. For lignocerate transfer, the KI was 
2 x 1o-4 M. 
From these observations we conclude that 
hydroxystearate transfer is carried out by a 
third enzyme, but that the hydroxy acid thio 
ester has the ability to combine with a sec- 
ond, activity modifying site on the NFA 
transferases. 
A similar type of control was observed 
when nonradioactive 18 : 0 CoA was included 
with labeled h18:O CoA. Formation of h18:O 
ceramide was inhibited and the inhibition 
was of the noncompetitive type (Fig. 5). 
Thus this transferase too seems to have a 
reciprocal sensitive site. The K1 for the in- 
hibitor was 1.9 X 1OL4 RI. 
The same kind of competition study with 
labeled lignoceroyl CoA and unlabeled cere- 
bronoyl CoA showed that the latter acts as a 
noncompetitive inhibitor of 24: 0-ceramide 
formation. A Dixon plot yielded a KI of 
2.5 X 10-5. 
Ceramide synthesis in extraneural tissue. 
To determine how widespread the acyltrans- 
ferases are in tissues outside the brain, we 
assayed for ceramide synthesis in the liver of 
16-day-old mice, and the liver, kidney, heart, 
and spleen of 64-day-old mice (Table VII). 
The near-absence of 18:0 and h18:O trans- 
ferases in the extraneural tissues was strik- 
ing. The observation that h24:O activity 
could be present without h18:O activity sug- 
gests that two different transferases exist for 
the HFA as well as for the NFA. 
Side-reactions in the formation of ceramides. 
In the study of NFA ceramide biosynthesis, 
we noted the formation by brain microsomes 
of free fatty acids and an assortment of polar 
lipids (9). The same was noted in this study 
with lignocerate and the hydroxy acids, the 
latter yielding about six unidentified polar 
lipids on the oxalate TLC plates. The hy- 
drolytic formation of free HFA was found to 
stop after about 30 min in the case of h18:0, 
but to continue for over 60 min in the case of 
1‘ 
1.4 - 8 
0 0.16 0.32 
HYDROXYSTEAROYL CoA(mN 
FIG. 4. Inhibition of NFA ceramide formation 
by h18:O CoA, in mouse brain microsomes. A: 
Dixon plots (35) for two concentrations of labeled 
stearoyl CoA (upper line, 0.16 mu; lower line, 0.32 
mu). B: Plots for two concentrations of labeled 
lignoceroyl CoA (upper line, 0.08 mnn; lower line, 
0.16 mu). V is expressed as nmoles ceramide 
formed in 15 min by 2 mg protein. 
h24:O (Fig. 6). Since ceramide formation 
from h24:O had been noted to stop after 
about 30 min, we had thought that all the 
h24:O CoA was hydrolyzed at this point. 
Perhaps a portion of the cerebronoyl CoA is 
bound to a membrane region that is accessi- 
ble to a thio ester hydrolase but not the 
ceramide-forming enzyme. 
The formation of polar lipids from the 
HFA CoA’s followed time courses like those 
of free fatty acid formation (Fig. 7). These 
syntheses took place even in the absence of 
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exogenous sphingosine but only to a small 
extent with heated microsomes. 
The extraneural tissues of the mouse also 
contain thio ester hydrolases, as well as the 
synthetic capacity for forming polar lipids 
from the NFA and HFA CoA’s (Table 
VIII). The differences in relative reactivities 
in different organs are suggestive of the ex- 
istence of separate hydrolases for the differ- 
ent substrates. 
DISCUSSION 
It now seems clear that HFA ceramides 
are biosynthesized by acyltransferases from 
long chain bases and HFA CoA’s. On the 
basis of our comparisons with the four differ- 
ent substrates and the competition experi- 
ments, we suggest that the activities found 
I I I 
0 0.08 0.16 0.24 
STEAROYL CoA (mM1 
FIG. 5. Inhibition of hydroxystearoyl sphingo- 
sine formation by stearoyl CoA, in brain micro- 
somes from 16-day-old mice. Upper line: with 
0.08 mM h18:O CoA; lower line: with 0.16 mu 
h18:O CoA. 
with HFA CoA’s are due to specific trans- 
ferases and are not a reflection of nonspecific- 
ity on the part of the NFA transferases. 
This finding does not rule out the existence 
of a second synthesizing system for HFA 
ceramide synthesis, a hydroxylase active on 
NFA ceramides, but it does weaken the likeli- 
hood. Evidence for a hydroxylase that forms 
2-HFA directly from free NFA (21, 22) is 
also consistent with our findings. The HFA 
kinase which forms HFA CoA has yet to be 
characterized; there is only a brief observa- 
tion on the synthesis of h16:O CoA in liver 
(23). 
Our comparative assays with the long and 
very long acyl CoA’s point strongly to the 
conclusion that separate enzymes are in- 
volved, both for the NFA and HFA. If the 
specificities are relatively distinct (e.g., the 
24:0 transferase surely is active toward all 
the fatty acids between 22:0 and 26 :0 but 
not toward the shorter acids), these enzymes 
then specify the distribution of fatty acids in 
the sphingolipids. The sharpness of this 
specificity was indicated in our previous 
study, which found a very wide difference in 
the rates of palmitoyl and stearoyl sphingo- 
sine formation in brain microsomes (9). 
It will be interesting to compare the trans- 
ferase activities involved in the formation of 
the unsaturated ceramides. Nervonic acid 
(24:l) and hydroxy nervonic acid are two 
major unsaturated sphingolipid acids, with 
the corresponding A7 acids close behind (24). 
In our examination of ceramide formation 
from lS:O and 18: 1, we found a remarkably 
low activity toward the latter and oleate is 
indeed a distinctly minor acid in the sphingo- 
TABLE VII 




Liver.34 Kidney,, Spleen@ Hea& 
(nmoles/lS min/2 mg) 
1s:o 2.41 0.07 0.03 0.13 0.09 0.02 
h18:O 1.22 0.06 0.04 0.11 0.07 0.02 
24:0 0.84 4.42 6.27 7.73 6.15 0.55 
h24:O 0.57 2.73 3.28 3.78 2.75 0.22 
a The subscripts next to the tissue name indicate the ages of the donors. 
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FIG. 6. Free fatty acid formed by mouse brain 
microsomes from acyl CoA as a function of incuba- 
tion duration. Upper curve, h18:O; lower curve, 
h24:O. Mouse age: 16 days. 
15 30 45 60 
TIME(min) 
FIG. 7. Polar lipids formed by mouse brain 
microsomes from acyl CoA as a function of incuba- 
tion duration. Upper curve, h24:O; lower curve, 
h18:O. 
lipids. Either the enzymes handling the 
very long acids have no such discrimination 
against the double bond, or-if they are like 
the 18:0 transferasethere is an additional 
enzyme or enzymes for the very long unsatu- 
rated acids. 
While our data seem to explain the exist- 
ence of two clusters of fatty acid chain 
lengths, they do not explain why NFA and 
HFA galactocerebrosides occur in brain in 
fairly equal proportions. The galactosyl- 
transferase which forms these cerebrosides 
acts far faster on HFA ceramides than on 
NFA ceramides. We had thought, when we 
began the current study, that we might find 
a reverse situation with the acyltransferases 
that form the two types of ceramides. Our 
data do show a more rapid reaction with 
24: 0 CoA than with h24: 0 CoA, but the 
difference is not great and it may be that the 
NFA hydroxylase or the HFA thiokinase is 
the rate-limiting step in HFA cerebroside 
formation. A more intriguing, alternate 
hypothesis is that HFA cerebrosides really 
are formed much more rapidly than the NFA 
cerebrosides and that they occupy a special 
role in membranes, undergoing much more 
rapid turnover than the latter. Such a com- 
parison, with the fatty acids of the two types 
of cerebrosides (25), revealed that the HFA 
incorporated about five t’imes the radioac- 
tivity from 3H- or 14C-labeled acetate than 
the NFA. A more precise comparison of the 
turnover rates cannot be made because the 
experiment was not continued long enough 
to delineate the decay curve. (In the case of 
[14C]acetate, reutilization of the fatty acids 
or the ceramides obscured the decay.) It 
TABLE VIII 
FORMATION OF SIDE-PRODUCTS FROM ACYL COENZYME A INCUBATIONS" 
Acyl CoA Amount of radioactive lipid formed (nmoles) - 
Liver Kidney Spleen Heart 
FFA PL FFA PL FFA PL FFA PL 
18:0 19.4 10.3 4.0 4.9 8.6 8.0 11.1 5.7 
h18:O 5.5 2.1 10.2 1.0 5.1 2.3 4.6 1.8 
24:0 3.7 15.0 6.1 10.2 2.1 12.1 4.4, 12.8 
h24:o 2.9 1.7 4.4 0.8 4.1 3.0 2.3 1.6 
a Data from incubations with microsomes (2 mg protein) from five 64-day-old mice. Incubations as 
in standard procedure. FFA, free fatty acid. PL, polar lipids. 
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would be of interest to follow the turnovers 
of the two groups of cerebrosides with 3H- 
hexose, with which reutilization in the 
galactose moiety would be minor. 
Our observation that extraneural organs 
exhibited verv low stearate transferase ac- 
tivity, but high lignocerate activity (com- 
pared with brain) was unexpected. Sphingo- 
myelin of extraneural tissues contains a fair 
proportion of 18:0 (although 24:O tends to 
be more prevalent), yet it would seem from 
the ceramide-forming activities that 18 : 0 
ceramide must be a difficultly synthesized 
compound. Perhaps this signifies that the 
ceramide-CDPcholine route in the extra- 
neural organs of the mouse is a very minor 
one, and that most of their sphingomyelin is 
made from acyl Co-4 and sphingosyl phos- 
phoryl choline (26). This comparison is 
presently under study in this laboratory. The 
glycosphingolipids of extraneural organs 
constitute a minor proportion compared with 
sphingomyelin. It is of interest that 24:0 
seems to be the major acid in these lipids, 
and 18:O is rather rare (27-29) ; these data 
agree with our transferase data, implicating 
the ceramide-forming enzymes as the con- 
trollers of fatty acid distribution in the ex- 
traneural, as well as neural, glycolipids. 
The high h24:O transferase activity in ex- 
traneural organs poses a similar question, as 
in brain, of a possible specially active 
metabolic role. The content of HFA outside 
of the nervous system is quite low (30). 
Our observation that neuronal cell prepara- 
tions contain acyltransferases for synthesiz- 
ing the HFA and very long chain NFA cera- 
mides (Table V) is consistent with our pre- 
vious observation (11) that neurons contain 
the galactosyltransferase that acts on HFA 
ceramides. Thus it is apparent, in contrast to 
the assumption of yesteryears, that neurons 
contain several or all of the necessary en- 
zymes for synthesizing galactocerebroside. 
These enzymes explain the finding of NFA 
and HFA galactocerebrosides in neuronal 
preparations (3133). 
We found that the nonenzymatic forma- 
tion of HFA ceramide went at an appreciable 
rate in the absence of tissue, but was slowed 
considerably by the addition of heat-de- 
natured or undenatured tissue. Similar non- 
enzymatic acylation of amino lipids, sphingo- 
syl phosphoryl choline and psychosine, had 
been observed by others (26,34). The heated 
enzyme no doubt slows the nonenzymatic re- 
action by sequestering the acyl CoA, and 
possibly the amino lipid too, and it appears 
likely (Table I) that the amount of binding 
is the same in the undenatured enzyme 
preparation. Thus we feel that it is correct to 
subtract the blank value obtained with heat- 
denatured microsomes. We have previously 
reported a serious blank activity in alkali- 
nized reaction mixtures containing stearoyl 
CoA and sphingosine (9). However the non- 
enzymatic formation of NFA ceramide under 
the conditions used in this study was very 
slight. It is evident from this difference, 
and from a TLC study of the acyl CoA’s 
(16), that the hydroxyl group in the 2-posi- 
tion activates the thio ester linkage. 
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